Jun 13, 2008
What's your opinion with the monotherapy?
Should I stick with it as long as it's working for me?
Thanks for any opinion you may have.
| Response from Dr. Frascino
In selected individuals, maintenance monotherapy with lopinavir/ritonavir (Kaletra) appears to be associated with a low risk of virologic rebound and/or the development of protease inhibitor resistance. However, whether or not this strategy should be used in a non-clinical trial setting remains debatable at best, particularly in light of the fact the new nucleoside reverse transcriptase inhibitors are now safer and have fewer side effects (lipoatrophy and other complications mediated by mitochondrial toxicity). In general I would reserve Kaletra monotherapy for individuals in a clinical trial where they are closely monitored or for folks who are intolerant of the other therapies. That said, it's always hard to argue with success. And you've obviously been successful so far. Certainly if someone is using monotherapy, adherence becomes even a more critical issue. Personally I would feel more confident using combination therapy.
Get Email Notifications When This Forum Updates or Subscribe With RSS
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.